Tapentadol Hcl
Brand name: Nucynta
Rank #324 of 500 drugs by total cost
$33.6M
Total Cost
29,886
Total Claims
$33.6M
Total Cost
1,415
Prescribers
$1,124
Cost per Claim
1,241
Beneficiaries
29,933
30-Day Fills
$24K
Avg Cost/Provider
21
Avg Claims/Provider
About Tapentadol Hcl
Tapentadol Hcl (sold as Nucynta) was prescribed 29,886 times by 1,415 Medicare Part D providers in 2023, costing the program $33.6M. At $1,124 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 321 | Dalfampridine (Dalfampridine Er) | $34.1M | 40,425 |
| 322 | Olmesartan Medoxomil (Olmesartan Medoxomil) | $33.8M | 1,102,412 |
| 323 | Niraparib Tosylate (Zejula) | $33.7M | 2,206 |
| 324 | Tapentadol Hcl (Nucynta) | $33.6M | 29,886 |
| 325 | Dorzolamide Hcl/Timolol Maleat (Dorzolamide-Timolol) | $33.5M | 1,096,480 |
| 326 | Morphine Sulfate (Morphine Sulfate Er) | $33.2M | 1,023,056 |
| 327 | Budesonide (Budesonide Dr) | $33.1M | 120,202 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology